Would you pay $1.41 for 15 minutes of your iPhone battery-life?
A significant win for Qualcomm for its non-SEPs against Apple in a trail San Diego The jury said yes. I mean they agreed that Apple has infringed Qualcomm’s three patents that...
A significant win for Qualcomm for its non-SEPs against Apple in a trail San Diego The jury said yes. I mean they agreed that Apple has infringed Qualcomm’s three patents that...
Editor’s note: This is the first in a series of articles that explores the sometimes obtuse process of standardizing, patenting and licensing cellular technologies. Answers to the questions you...
All you need to know about the face off at the District Court in San Diego; infringement claims on patents that improve battery-life, and cost of smartphones under scrutiny...
From the very beginning, when the standardization was advanced by almost a year, 5G has always been on the accelerated path. The acceleration is visible across the board–in prototyping,...
We are only days away from the biggest telecom show, Mobile World Congress (MWC) 2019. The industry announcements are slowly trickling in and will soon turn into a flood!...
Analyzing the long term impacts of FTC’s activist litigation In all the chaos of allegations, counter allegations, scores of testimonies, rebuttals, cross-examinations, and others, I humbly request that Judge...
The ongoing saga between FTC and Qualcomm It is unbelievable when one of the world’s richest companies complains that it is an undue burden to pay for the innovations...
The telecom industry made big strides in making 5G real in 2018 with increasing awareness of the transformational nature of 5G in the general populace. Nevertheless, this year will...
Have you heard the phrase “converting poison into medicine?” Well, that’s kind of what is happening to the PC industry now. Let me explain. Not too long ago, the...
The side effect of all the attention and hype of 5G is the close scrutiny of its standards development, and undue confusion and unfounded fear because of even benign...